Leiden Jeffrey M
SEC-identified person · CIK 1242825 Identifier-verified
Public-company roles (from insider filings)
| Company | Capacity as filed | Filings |
|---|---|---|
| Odyssey Therapeutics, Inc. ODTX | Director | filed 2026–2026 |
| Vertex Pharmaceuticals INC / MA VRTX | Director · Executive Chairman | filed 2009–2026 |
| Revolution Healthcare Acquisition Corp. REVH | Director | filed 2021–2021 |
| Quest Diagnostics INC dgx | Director | filed 2014–2018 |
| Millennium Pharmaceuticals INC MLNM | Director | filed 2007–2008 |
| Abbott Laboratories ABT | Director · President and COO | filed 2006–2006 |
All roles under one Commission-assigned identifier - the same person by the SEC's own record, not by name matching. From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.